The Addiction Technology Transfer Center Network (ATTC)

The Addiction Technology Transfer Center (ATTC) Network promotes the adoption and implementation of evidence- based, recovery-oriented, culturally appropriate practices for people who have, or who are at risk of developing, substance use disorders across the globe. Funded by the Substance Abuse and Mental Health Services Administration, the Network includes 10 Regional Centers, 2 National Focus Area Centers, and a Network Office serving the United States, Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Palau, the Marshall Islands, Micronesia, and the Mariana Islands. Additionally, the President’s Emergency Plan for Aids Relief supports international HIV ATTCs in Ukraine and Central Asia, South Africa, Southeast Asia, and Vietnam.

Please visit ATTC’s website for more information on their events and activities:

Telehealth Learning Series

The Addiction Technology Transfer Center (ATTC) Network, the Center for Excellence on Protected Health Information (CoE-PHI), the National Consortium of Telehealth Resource Centers, and the Center for the Application of Substance Abuse Technologies (CASAT) at the University of Nevada - Reno (UNR) are facilitating these FREE, national online discussion and resource sharing opportunity for substance use disorder (SUD) treatment providers and peer support specialists faced with transitioning their services to the use of telephone and

Internet-Delivered Drug and Alcohol Treatment

Shulman, M., Campbell, A., Pavlicova, M., Hu, M. C., Aharonovich, E., & Nunes, E. V. (2018). Cognitive functioning and treatment outcomes in a randomized controlled trial of internet‐delivered drug and alcohol treatment. The American journal on addictions, 27(6), 509-515.
Publication Date

Often individuals with substance use disorders show signs of impaired attention/ mental control, information processing or general cognitive functioning. Mental impairment can have an impact on the extent an individual can engage with intervention, and it has been found that cognitive impairment is associated with poorer outcomes in treatment.